R. Hofmann
-
Efficacy and Safety of Inhaled Recombinant Interleukin-2 in High-Risk Renal Cell Cancer Patients Compared with Systemic Interleukin-2: an Outcome Study
Edith Huland, A. Burger, J. Fleischer, P. Fornara, E. Hatzmann, A. Heidenreich, H. Heinzer, H. Heynemann, L. Hoffmann, R. Hofmann, H. Huland, I. Kämpfer, M. Kindler, H. Kirchner, G. Mehlhorn, T. H. Moniak, U. Rebmann, J. Roigas, T. H. Schneider, D. Schnorr, H.-J. Schmitz, R. Wenisch, Z. Varga, J. Vinke
2003, Vol. 49, Issue 5, pp. 183-190 -
A Prospective Open-Label Single-Arm Phase II Study of Chimeric Monoclonal Antibody cG250 in Advanced Renal Cell Carcinoma Patients
Zoltan Varga, P. De Mulder, W. Kruit, A. Hegele, R. Hofmann, C. Lamers, S. Warnaar, C. Mala, S. Ullrich, P. Mulders
2003, Vol. 49, Issue 2, pp. 74-77
